NCT03787589

Brief Summary

This study will be conducted over a 3 year time period. This is a trial of an exercise intervention vs. standard of care in patients receiving chronic dialysis. The specific aims will be to determine feasibility of patient recruitment, adherence to the exercise program, and efficacy of the intervention on patient important outcomes. The exercise intervention will be delivered to randomized participants for 12 months, and consist of the prescribed use of Nordic Walking poles, online resources for exercise in the home, regular use of a pedometer to monitor progress, and regular verbal encouragement to exercise (monthly) by dialysis unit staff. Both groups will receive the same standard of care co-interventions including individualized dialysis prescriptions and health-care interactions according to practices at their centre.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 26, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

April 15, 2019

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2025

Completed
Last Updated

June 26, 2024

Status Verified

June 1, 2024

Enrollment Period

5.8 years

First QC Date

October 1, 2018

Last Update Submit

June 24, 2024

Conditions

Keywords

Renal FailureHemodialysisPeritoneal DialysisExercise

Outcome Measures

Primary Outcomes (2)

  • Recruitment Feasibility

    The investigators will assess at each centre the number of participants receiving dialysis, approached for participation, eligible to participate and any reasons for non-participation.

    30 months

  • Adherence

    Two-week step counts with a pedometer will be monitored monthly in the treatment group, and at baseline, 6 and 12 months in the control group.

    12 months

Secondary Outcomes (7)

  • Hand Grip Strength

    12 months

  • Quality of Life using Vitality Subscale

    12 months

  • Sleep Quality

    12 months

  • Hospitalizations

    12 months

  • Hospital Length of Stay

    12 months

  • +2 more secondary outcomes

Study Arms (2)

Exercise Intervention

EXPERIMENTAL

Participants in this arm will receive standard of care along with the exercise prescription intervention

Behavioral: Exercise Prescription

Standard of Care

NO INTERVENTION

This group will receive standard of care treatment including regular verbal encouragement to exercise (monthly) by dialysis unit staff.

Interventions

Participants in the intervention group will be given an exercise prescription to increase their baseline steps by 1200 and 2000 steps per day at least 3 days a week over the first 3 months. If tolerated and accepted, the participants will increase their step counts by an additional 600 to 1000 steps per day at least 3 days a week for the next 3 months.This will be followed by a 6-month maintenance phase. The research coordinator will instruct the participants on the proper use of the Nordic walking poles which can be used to help participants achieve their prescribed number of steps. All participants will be encouraged to wear the pedometer throughout the trial in order to follow the step-count prescription and monitor adherence.

Exercise Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All ambulatory adult patients with end stage kidney disease
  • Treatment with peritoneal dialysis or hemodialysis for greater than six months
  • Able to understand English or French
  • Abuse to use Nordic Walking poles
  • Able and willing to provide informed consent

You may not qualify if:

  • Any absolute contraindication to exercise \[unstable angina, uncontrolled hypertension (systolic or diastolic blood pressure greater than 180 mmHg (millimeters of mercury) or greater than 110 mmHg, respectively), deemed not suitable for exercise by the treating physician\]
  • Baseline step count greater than 8000 steps a day
  • Planned living donor kidney transplant
  • Potential for recovery of renal function
  • Patients who feel unsafe using Nordic walking poles in place of their mobility aid
  • Participation in another interventional trial that may affect the results of this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ottawa Hospital

Ottawa, Ontario, K1H 1A2, Canada

RECRUITING

Related Publications (1)

  • Suri RS, Moist L, Lok C, Clase CM, Harris J, Reid RD, Ramsay T, Zimmerman D. A Simple Exercise Program for Patients With End-Stage Kidney Disease to Improve Strength and Quality of Life: Clinical Research Protocol. Can J Kidney Health Dis. 2023 Oct 26;10:20543581231205160. doi: 10.1177/20543581231205160. eCollection 2023.

MeSH Terms

Conditions

Renal InsufficiencyMotor Activity

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesBehavior

Study Officials

  • Deborah Zimmerman, MD, MSc

    Ottawa Hospital Research Institute

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Deborah Zimmerman, MD, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2018

First Posted

December 26, 2018

Study Start

April 15, 2019

Primary Completion

January 31, 2025

Study Completion

September 15, 2025

Last Updated

June 26, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will share

The study protocol, manual of operations and consent form will be made available by contacting the corresponding author. De-identified patient data will be available from 12 months to 3 years after manuscript publication to researchers with methodologically sound proposals approved by the principal investigator.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
One year after publication up to 3 years post publication
Access Criteria
researchers with methodologically sound proposals approved by the principal investigator

Locations